Cargando…

Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome

Background: The present study was conducted to determine the response to treatment in patients with GTN, the survival rate and to investigate the outcomes of first pregnancy after chemotherapy. Materials and Methods: The treatment protocol was based on the FIGO Staging of GTN and the Modified WHO Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Aznab, Mozaffar, Nankali, Anisodowleh, Daeichin, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375376/
https://www.ncbi.nlm.nih.gov/pubmed/30774829
_version_ 1783395365140037632
author Aznab, Mozaffar
Nankali, Anisodowleh
Daeichin, Sara
author_facet Aznab, Mozaffar
Nankali, Anisodowleh
Daeichin, Sara
author_sort Aznab, Mozaffar
collection PubMed
description Background: The present study was conducted to determine the response to treatment in patients with GTN, the survival rate and to investigate the outcomes of first pregnancy after chemotherapy. Materials and Methods: The treatment protocol was based on the FIGO Staging of GTN and the Modified WHO Prognostic Scoring. Results: Complete remission was achieved with MTX in 100% of the low-risk patients and with combination therapy in 91% of the high-risk cases. Out of 27 low-risk patients, 21 had no metastasis 6 had lung metastasis, 18 preserved their fertility and conceived in the first year following the chemotherapy. Out of 3 patients who had developed invasive moles, 1 got pregnant after chemotherapy. Four of the patients with choriocarcinoma conceived in the first year following the chemotherapy. In the patient with placental site trophoblastic tumors, there was no pregnancy due to hysterectomy. Conclusion: GTN was found to be a chemosensitive condition, but more effective therapeutic protocols are therefore required.
format Online
Article
Text
id pubmed-6375376
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-63753762019-02-15 Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome Aznab, Mozaffar Nankali, Anisodowleh Daeichin, Sara Int J Hematol Oncol Stem Cell Res Original Article Background: The present study was conducted to determine the response to treatment in patients with GTN, the survival rate and to investigate the outcomes of first pregnancy after chemotherapy. Materials and Methods: The treatment protocol was based on the FIGO Staging of GTN and the Modified WHO Prognostic Scoring. Results: Complete remission was achieved with MTX in 100% of the low-risk patients and with combination therapy in 91% of the high-risk cases. Out of 27 low-risk patients, 21 had no metastasis 6 had lung metastasis, 18 preserved their fertility and conceived in the first year following the chemotherapy. Out of 3 patients who had developed invasive moles, 1 got pregnant after chemotherapy. Four of the patients with choriocarcinoma conceived in the first year following the chemotherapy. In the patient with placental site trophoblastic tumors, there was no pregnancy due to hysterectomy. Conclusion: GTN was found to be a chemosensitive condition, but more effective therapeutic protocols are therefore required. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018-10-01 /pmc/articles/PMC6375376/ /pubmed/30774829 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Aznab, Mozaffar
Nankali, Anisodowleh
Daeichin, Sara
Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title_full Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title_fullStr Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title_full_unstemmed Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title_short Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome
title_sort determination of clinical process and response rate to treatment in patients with gestational trophoblastic neoplasia (gtn) with low and high risk and evaluation of their first pregnancy outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375376/
https://www.ncbi.nlm.nih.gov/pubmed/30774829
work_keys_str_mv AT aznabmozaffar determinationofclinicalprocessandresponseratetotreatmentinpatientswithgestationaltrophoblasticneoplasiagtnwithlowandhighriskandevaluationoftheirfirstpregnancyoutcome
AT nankalianisodowleh determinationofclinicalprocessandresponseratetotreatmentinpatientswithgestationaltrophoblasticneoplasiagtnwithlowandhighriskandevaluationoftheirfirstpregnancyoutcome
AT daeichinsara determinationofclinicalprocessandresponseratetotreatmentinpatientswithgestationaltrophoblasticneoplasiagtnwithlowandhighriskandevaluationoftheirfirstpregnancyoutcome